NCT02707575 - Cytokeratin 8 Level in Age-related Macular Degeneration | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 26, 2016

Primary Completion Date

March 12, 2018

Study Completion Date

April 23, 2018

Conditions

Age-related Macular Degeneration

Interventions

DRUG

Ranibizumab

Three monthly consecutive injections of 0.5-mg ranibizumab will be performed. Aqueous humor samples will be taken each time an intravitreal injection in indicated and performed.

Trial Locations (2)

Unknown

Inje University Ilsan Paik Hospital, Goyang

Gangnam Severance Hospital, Seoul